References

  1. Fahr T. Idiopathische verkalkung der hirngefässe. Zentrabl Allg Pathol. 1930; 50:129-33.

  2. Ceccaldi B, El Maghraoui A, Mayaudon H, Dupuy O, Eulry F el al. Syndrome de Fahr et hyperparathyroïdie. Presse Med. 1999 Apr 3; 28(13):689.

  3. Nicolas G, Hannequin G. Idiopathic basal ganglia calcification (Fahr's disease). Pratique Neurologique - FMC. 2013;4(3):143–50.

  4. Rafai M, Bensghir M, Abouaala K, Baite A, Drissi Kamili N. Découverte fortuite d’un syndrome de Fahr suite à un accident vasculaire cérébral hémorragique. J Magh A Réa Méd Urg. 2011; 18:265.

  5. Farhat E, Naas A, Ben Sassi S, Hentati F, Zouari M. Rare manifestations of Fahr's syndrome: a report of 3 cases. JNS. 2013; 333(Suppl 1):e667. Google Scholar

  6. D’Anglejean Chatillon J, de Billy A, Dormont D et al. Calcifications idiopathiques des noyaux gris centraux (maladie de Fahr). Apport de l’IRM. Presse Med. 1988 Oct 8; 17(34):1760.

  7. Pfaender M, D'Souza WJ, Trost N, Litewka L, Paine M, Cook M. Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and coeliac disease: a case series. J Neurol Neurosurg Psychiatr. 2004; 75:1623-5. Google Scholar

  8. Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010 Jan; 112(1):1-10. PubMed | Google Scholar